Company Overview and News

 
Peterborough casino set to open Monday

2018-10-11 globalnews.ca
Ontario Gaming East Limited Partnership, a subsidiary of Great Canadian Gaming Corporation, says Shorelines Casino Peterborough on Crawford Drive will open at 5 p.m. on Oct. 15.
GCGMF GC

 
Ajax slots to remain open until at least 2026, province announces

2018-10-10 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
GCGMF GC AJAX

 
Exclusive: B.C. casino review contractor previously consulted for River Rock Casino

2018-10-05 globalnews.ca
WATCH ABOVE: Senator Larry Campbell refuses to answer questions about alleged money laundering in B.C. casino
GCGMF GC

 
Toronto missing out on securing local jobs, Jennifer Keesmaat says

2018-10-02 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
GCGMF GC

 
River Rock Casino employees identified in raid on suspected illegal gaming house

2018-10-01 cbc.ca
B.C.'s anti-gang agency informed the province's Gaming Policy Enforcement Branch about the presence of two River Rock Casino employees found in a raid on an illegal gaming house in Richmond last spring.
GCGMF GC

 
Exclusive: Documents allege complicity in money laundering in major investigation of River Rock Casino

2018-09-28 globalnews.ca
WATCH ABOVE: Senator Larry Campbell refuses to answer questions about alleged money laundering in B.C. casino
GCGMF GC

 
Great Canadian Gaming Corporation (GCGMF) CEO Rod Baker on Q2 2018 Results - Earnings Call Transcript

2018-08-15 seekingalpha
Great Canadian Gaming Corporation (OTCPK:GCGMF) Q2 2018 Results Earnings Conference Call August 14, 2018 5:00 PM ET
GCGMF GC

 
Clairvest Reports Fiscal 2019 First Quarter Results

2018-08-13 globenewswire
TORONTO, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Clairvest Group Inc. (TSX: CVG) today reported results for the fiscal 2019 first quarter ended June 30, 2018. (All figures are in Canadian dollars unless otherwise stated)
GCGMF GC CVG CVTGF

1
Pollard Banknote - Betting Big On Scratch And Win

2018-08-01 seekingalpha
Instant ticket lottery sales have been the fastest growing segment of the lottery industry for the past decade.
GCGMF PBL GC PBKOF SGMS IGT WACC

 
Clairvest Reports Fiscal 2018 Fourth Quarter and Year-End Results

2018-06-27 globenewswire
TORONTO, June 27, 2018 (GLOBE NEWSWIRE) -- Clairvest Group Inc. (TSX:CVG) today reported results for the fourth quarter and year ended March 31, 2018 and material events which occurred subsequent to year-end. (All figures are in Canadian dollars unless otherwise stated)
GCGMF GC CVG CVTGF

26
Great Canadian Gaming: Public Documents Prove Why Successful Capital Allocators Invested In Ontario

2018-06-25 seekingalpha
We expect its share price to ~double over the next four years and think downside is limited given the recent unwarranted selloff.
GCGMF BAMGF GC CZR BBU CVG CVTGF BAMKF BAM

32
CANADA STOCKS-TSX dips as falling oil prices weigh on energy stocks

2018-06-21 reuters
June 21 (Reuters) - Canada’s main stock index dipped on Thursday after lower oil prices dragged down shares of energy companies.
ASGTF ENBBF PXT PARXF ACBFF ENB CGC GCGMF ENB GC TWMJF ACB AIF CNQ WEED EBBNF

31
CANADA STOCKS - TSX rises 0.64 pct, helped by energy

2018-06-20 reuters
NEW YORK, June 20 (Reuters) - * The Toronto Stock Exchange’s S&P/TSX rose 104.42 points, or 0.64 percent, to 16,420.95. * The biggest contributor to the TSX gain was Toronto Dominion Bank, while the energy sector provided the biggest boost. * Leading the index were Canopy Growth Corp, up 6.7 percent, MEG Energy Corp, up 6.4 percent, and Bombardier Inc, up by 5.5 percent. * Lagging shares were Great Canadian Gaming Corp, down 10.
GOOS ACBFF MEG TCLAF TCLCF CGC TD GCGMF GC TWMJF ACB WEED BDRPF MEGEF

9
Great Canadian Gaming: Are Shareholders About To Roll Snake-Eyes?

2018-06-20 seekingalpha
Offers potential downside of -40% to -64% from its current price of $55.54/shr. Stock has rallied +135% LTM on the back of a key contract win.
GCGMF GC CZR BBU CVG PENN CVTGF

23
Clairvest - Buying Quality Private Equity Assets At A Discount

2018-06-19 seekingalpha
Bargain purchase of large casino asset from motivated seller will be realized on the next balance sheet.
GCGMF BAMGF GC BBU CVTGF BAMKF BAM

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

CUSIP: 389914102